HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial-Reference-Cited by-同舟云学术

HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial

Published:2015-01-01 Issue:1 Volume:68 Page:55-61
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Garrett Nigel J.,Werner Lise,Naicker Nivashnee,Naranbhai Vivek,Sibeko Sengeziwe,Samsunder Natasha,Gray Clive,Williamson Carolyn,Morris Lynn,Abdool-Karim Quarraisha,Abdool-Karim Salim S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference20 articles.

1. . Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.;Anderson;Sci Transl Med,2012

2. . Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.;Choopanya;Lancet,2013

3. . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.;Baeten;N Engl J Med,2012

4. . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.;Thigpen;N Engl J Med,2012

5. . Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.;Abdool Karim;Science,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the effects of cytokine biomarkers on HIV incidence: a case study for individuals randomized to pre-exposure prophylaxis vs. control;Frontiers in Public Health;2024-06-25

2. Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide;JAIDS Journal of Acquired Immune Deficiency Syndromes;2017-09-01

3. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial;PLOS ONE;2017-06-28

4. Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression;Journal of Virology;2017-04-15

5. From Bench to Bedside: Lessons from HIV Natural History Cohort Studies;The CAPRISA Clinical Trials: HIV Treatment and Prevention;2017